US-based biopharmaceutical company Kadmon Holdings (Kadmon) has announced a public offering of common stock shares to raise up to $40m in total.

The company plans to use the funds towards clinical development of its product candidates and general corporate purposes.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Antares Pharma has announced plans to raise $30m through a public offering of its common stock shares.

"Antares Pharma has announced plans to raise $30m through a public offering of its common stock shares."

The US-based specialist pharmaceutical company plans to use the funds for general corporate purposes.

SK Capital has announced plans to acquire Perrigo API, the active pharmaceutical ingredients (API) business of Perrigo Company, for $110m.

SK Capital is a private investment firm based in the US, while Perrigo is an Irish healthcare company. The transaction will complement the existing businesses of SK Capital.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact